Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Jointown Pharmaceutical Group Co's Net Margin % or its related term are showing as below:
SHSE:600998'
s Net Margin % Range Over the Past 10 Years
Min: 1.23 Med: 1.6 Max: 2.77
Current: 1.23
SHSE:600998's Net Margin % is ranked worse than 55.46% of 119
companies
in the Medical Distribution industry
Industry Median: 1.38
vs SHSE:600998: 1.23
Jointown Pharmaceutical Group Co (SHSE:600998) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Jointown Pharmaceutical Group Co Net Margin % Related Terms
Jointown Pharmaceutical Group Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jointown Pharmaceutical Group Co Net Margin % Chart
SHSE:600998 vs MCK, COR, CAH: Net Margin % Comparison
For the Medical Distribution subindustry, Jointown Pharmaceutical Group Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jointown Pharmaceutical Group Co Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Jointown Pharmaceutical Group Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Jointown Pharmaceutical Group Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jointown Pharmaceutical Group Co (SHSE:600998) has a Net Margin % of 1.64% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Jointown Pharmaceutical Group Co and its competitors. This is near median its historical median of 1.60. Over the past decade, Jointown Pharmaceutical Group Co's Net Margin % has ranged from 1.23 to 2.77. According to the industry distribution chart, Jointown Pharmaceutical Group Co ranks #66 out of 119 companies in the Medical Distribution industry, placing it in the top 55.5%.
Is Jointown Pharmaceutical Group Co's Net Margin % too high?
Jointown Pharmaceutical Group Co's current Net Margin % of 1.64% is near median its 10-year median of 1.60. Over the past 10 years, this metric has ranged from a low of 1.23 to a high of 2.77. The Medical Distribution industry median Net Margin % is 1.38. Jointown Pharmaceutical Group Co's value of 1.64% is 18.8% above this industry median. Based on the distribution chart, Jointown Pharmaceutical Group Co ranks #66 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Jointown Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jointown Pharmaceutical Group Co's Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Jointown Pharmaceutical Group Co ranks #66 out of 119 companies for Net Margin %. This places Jointown Pharmaceutical Group Co in the lower half of its industry. The industry median Net Margin % is 1.38. Jointown Pharmaceutical Group Co's value of 1.64% is 18.8% above this benchmark. Historically, Jointown Pharmaceutical Group Co's own Net Margin % has ranged from 1.23 to 2.77 over the past decade. While the company's 10-year median is 1.60 vs. the industry median of 1.38, Jointown Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.38, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jointown Pharmaceutical Group Co's current Net Margin % of 1.64% is 18.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Jointown Pharmaceutical Group Co and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jointown Pharmaceutical Group Co's current Net Margin % is 1.64%, which is near median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jointown Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co (SHSE:600998) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.58, compared to a current price of ¥5.12 — trading 8.2% below its estimated fair value. The current Net Margin % is 1.64%, which is near median its 10-year median of 1.60 and 18.8% above the Medical Distribution industry median of 1.38. Jointown Pharmaceutical Group Co's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Jointown Pharmaceutical Group Co (SHSE:600998), the current Net Margin % is 1.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jointown Pharmaceutical Group Co (SHSE:600998) Overvalued in 2026?
Based on GuruFocus' analysis, Jointown Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥5.12 is trading 8.2% below its estimated GF Value™ of ¥5.58.
GuruFocus considers Jointown Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:600998:
Net Margin %: 1.64% (near median its 10-year median of 1.60)
GF Value™: ¥5.58 vs. price of ¥5.12 (8.2% below fair value)
Industry Position: 18.8% above the Medical Distribution median (#66 of 119)
No single metric tells the full story. See the SHSE:600998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jointown Pharmaceutical Group Co Business Description
Jointown Pharmaceutical Group Co Ltd is engaged in the business of wholesaling drugs and medical devices. The company offers logistics and other value-added services and mainly serves medical institutions, wholesale enterprises, and retail pharmacies.
81GF Score
Get the complete analysis for SHSE:600998
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600998 has been successfully added to your 
